中国武汉新冠康复者出院18个月后肺弥散功能障碍的发生率及影响因素
Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
作者信息
Xu Bo, Ma Fu-Qiang, He Cong, Wu Zi-Qi, Fan Cun-Yu, Mao He-Rong, Zhang Ji-Xian, Yang Min, Hu Zuo-Wei
机构信息
Hubei University Of Chinese Medicine, Wuhan, 430065, China.
Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China.
出版信息
J Infect. 2022 Jan 2. doi: 10.1016/j.jinf.2021.12.040.
Abstract
The Publisher regrets that this article is an accidental duplication of an article that has already been published, http://dx.doi.org/10.1016/j.jinf.2021.12.020. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
相似文献
1
Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
J Infect. 2022 Jan 2. doi: 10.1016/j.jinf.2021.12.040.
2
Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
J Infect. 2022 Feb;84(2):e16-e18. doi: 10.1016/j.jinf.2021.12.020. Epub 2021 Dec 25.
3
Interpretable machine-learning model for Predicting the Convalescent COVID-19 patients with pulmonary diffusing capacity impairment.
BMC Med Inform Decis Mak. 2023 Aug 29;23(1):169. doi: 10.1186/s12911-023-02192-6.
4
Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
J Korean Med Sci. 2020 Dec 7;35(47):e418. doi: 10.3346/jkms.2020.35.e418.
5
Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.
J Infect Dis. 2021 Nov 16;224(9):1473-1488. doi: 10.1093/infdis/jiab181.
6
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11.
7
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5.
8
Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China.
Clin Infect Dis. 2022 Jun 10;74(11):1953-1965. doi: 10.1093/cid/ciab703.
9
One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study.
JAMA Neurol. 2022 May 1;79(5):509-517. doi: 10.1001/jamaneurol.2022.0461.
10
Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up.
Eur Respir J. 2021 Jul 22;58(1). doi: 10.1183/13993003.03677-2020. Print 2021 Jul.
Zotero 插件